Eledon Pharmaceuticals (ELDN) Shareholder's Equity Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.62% |
| Dec 31, 2025 | -15.71% |
| Sep 30, 2025 | 10.46% |
| Jun 30, 2025 | 40.01% |
| Mar 31, 2025 | 38.05% |
| Dec 31, 2024 | 45.84% |
| Sep 30, 2024 | 8.79% |
| Jun 30, 2024 | -43.12% |
| Mar 31, 2024 | -55.50% |
| Dec 31, 2023 | -39.83% |
| Sep 30, 2023 | 14.20% |
| Jun 30, 2023 | 15.26% |
| Mar 31, 2023 | 25.22% |
| Dec 31, 2022 | 4.11% |
| Sep 30, 2022 | 46.91% |
| Jun 30, 2022 | 44.83% |
| Mar 31, 2022 | 46.25% |
| Dec 31, 2021 | 128.79% |
| Sep 30, 2021 | 41.35% |
| Jun 30, 2021 | 35.64% |
| Mar 31, 2021 | 29.03% |
| Dec 31, 2020 | 132.89% |
| Sep 30, 2020 | -21.45% |
| Jun 30, 2020 | -35.34% |
| Mar 31, 2020 | -33.59% |
| Dec 31, 2019 | -38.02% |
| Sep 30, 2019 | -33.35% |
| Dec 31, 2018 | 17.74% |